Passamonti, Francesco
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico,
Italy
2025 Rank: 42,945
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1,292 out of 166,615 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 42,945 | 35,946 |
| Total Cites | 22,922 | 29,770 |
| H-index | 70 | 80 |
| Hm-index | 16 | 17 |
| Number of Single Authored Papers | 7 | 7 |
| Total Cites to Single Authored Papers | 87 | 110 |
| Number of Single+First Authored Papers | 65 | 65 |
| Total Cites to Single+First Authored Papers | 3,964 | 4,981 |
| Number of Single+First+Last Authored Papers | 118 | 118 |
| Total Cites to Single+First+Last Authored Papers | 4,864 | 6,224 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 11,811 | 13,263 |
| Ratio of Total Citations to Distinct Citing Papers | 1.94 | 2.24 |
| Self-Citation Percentage |
23.00%
|
|
Passamonti, Francesco
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico,
Italy
2024 Rank: 45,044
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1,352 out of 157,372 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 45,044 | 38,667 |
| Total Cites | 20,099 | 26,153 |
| H-index | 66 | 75 |
| Hm-index | 15 | 16 |
| Number of Single Authored Papers | 7 | 7 |
| Total Cites to Single Authored Papers | 85 | 107 |
| Number of Single+First Authored Papers | 63 | 63 |
| Total Cites to Single+First Authored Papers | 3,614 | 4,572 |
| Number of Single+First+Last Authored Papers | 112 | 112 |
| Total Cites to Single+First+Last Authored Papers | 4,368 | 5,623 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 10,328 | 11,559 |
| Ratio of Total Citations to Distinct Citing Papers | 1.95 | 2.26 |
| Self-Citation Percentage |
23.15%
|
|
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1,467 out of 147,556 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 48,455 | 41,990 |
| Total Cites | 17,679 | 22,936 |
| H-index | 63 | 71 |
| Hm-index | 14 | 15 |
| Number of Single Authored Papers | 7 | 7 |
| Total Cites to Single Authored Papers | 77 | 97 |
| Number of Single+First Authored Papers | 60 | 60 |
| Total Cites to Single+First Authored Papers | 3,283 | 4,145 |
| Number of Single+First+Last Authored Papers | 103 | 103 |
| Total Cites to Single+First+Last Authored Papers | 3,923 | 5,042 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 9,025 | 10,039 |
| Ratio of Total Citations to Distinct Citing Papers | 1.96 | 2.28 |
| Self-Citation Percentage |
22.92%
|
|
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1,536 out of 138,599 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 49,577 | 43,976 |
| Total Cites | 15,674 | 20,354 |
| H-index | 61 | 69 |
| Hm-index | 14 | 14 |
| Number of Single Authored Papers | 7 | 7 |
| Total Cites to Single Authored Papers | 69 | 87 |
| Number of Single+First Authored Papers | 56 | 56 |
| Total Cites to Single+First Authored Papers | 2,913 | 3,664 |
| Number of Single+First+Last Authored Papers | 92 | 92 |
| Total Cites to Single+First+Last Authored Papers | 3,457 | 4,423 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 8,004 | 8,900 |
| Ratio of Total Citations to Distinct Citing Papers | 1.96 | 2.29 |
| Self-Citation Percentage |
22.99%
|
|
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1,550 out of 127,911 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 50,534 | 44,462 |
| Total Cites | 14,700 | 19,224 |
| H-index | 59 | 67 |
| Hm-index | 14 | 14 |
| Number of Single Authored Papers | 7 | 7 |
| Total Cites to Single Authored Papers | 64 | 82 |
| Number of Single+First Authored Papers | 54 | 54 |
| Total Cites to Single+First Authored Papers | 2,737 | 3,459 |
| Number of Single+First+Last Authored Papers | 88 | 88 |
| Total Cites to Single+First+Last Authored Papers | 3,244 | 4,173 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 7,598 | 8,453 |
| Ratio of Total Citations to Distinct Citing Papers | 1.93 | 2.27 |
| Self-Citation Percentage |
23.53%
|
|
Passamonti, Francesco
Azienda Ospedaliera Ospedale di Circolo e Fondazione Macchi di Varese,
Italy
2020 Rank: 55,060
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1,678 out of 108,509 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 55,060 | 45,928 |
| Total Cites | 12,538 | 16,561 |
| H-index | 52 | 63 |
| Hm-index | 13 | 14 |
| Number of Single Authored Papers | 7 | 7 |
| Total Cites to Single Authored Papers | 60 | 77 |
| Number of Single+First Authored Papers | 53 | 53 |
| Total Cites to Single+First Authored Papers | 2,332 | 2,990 |
| Number of Single+First+Last Authored Papers | 84 | 84 |
| Total Cites to Single+First+Last Authored Papers | 2,748 | 3,588 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 6,704 | 7,452 |
| Ratio of Total Citations to Distinct Citing Papers | 1.87 | 2.22 |
| Self-Citation Percentage |
24.29%
|
|
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.